Cancer Genomics & Proteomics (CGP) is an international peer-reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising. The first issue of CGP circulated in January 2004.
Cancer Genomics & Proteomics is a journal of the International Institute of Anticancer Research. From January 2013 CGP is converted to an online-only open access journal.
Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.
Impact factor (2021-2022): 3.395
Publication Data
Cancer Genomics & Proteomics appears bimonthly online-only and open access through the Stanford University Highwire Press. Each annual volume contains six issues and index.
Articles in Cancer Genomics & Proteomics are regularly indexed in the following bibliographic services: Pubmed, Pubmed Central, Essential Science Indicators, Current Contents Life Sciences, Science Citation Index Expanded (WEB OF SCIENCE), CAS (Chemical Abstracts Service), BIOLOGICAL ABSTRACTS, EMBASE and BIOBASE, (Elsevier Bibliographic Databases), Compendex, GEOBASE, EMBiology, FLUIDEX, SCOPUS, BIOSIS Previews, LEEDS MEDICAL INFORMATION, CSA ILLUMINA (Cambridge Scientific Abstracts, including: Oncogenes & Growth Factors, Genetics, Medical & Pharmaceutical Biotechnology, Bioengineering), Google Scholar, All-Russian Institute of Scientific and Technical Information – VINITI Abstracts Journal, Sociedad Iberoamericana de Información Científica (SIIC Data Bases), PubsHub.